Company Filing History:
2 out of 2 
1 out of 349 
1 out of 1 Years Active: 1991-2003
Title: William Drell: Innovator in Opioid Treatment
Introduction
William Drell is a notable inventor based in San Diego, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of opioid-induced side effects. With a total of 7 patents to his name, Drell's work has the potential to improve the quality of life for many patients.
Latest Patents
Drell's latest patents focus on the use of methylnaltrexone and related compounds. One of his patents describes a method for preventing or treating opioid-induced changes in gastrointestinal motility. This method involves administering methylnaltrexone or another quaternary derivative of noroxymorphone to a patient either prior to opioid administration or after the onset of side effects. The administration is done orally in an enterically coated form. Another patent addresses the treatment of chronic opioid use side effects. This method involves administering a quaternary derivative of noroxymorphone in an amount sufficient to prevent or treat the side effect in patients who have been chronically taking opioids.
Career Highlights
Throughout his career, Drell has worked with various companies, including Ur Labs, Inc. His innovative approaches have garnered attention in the medical community, particularly for their implications in pain management and opioid treatment.
Collaborations
Drell has collaborated with notable individuals in his field, including Joseph F Foss and Michael F Roizen. These collaborations have likely contributed to the advancement of his research and the development of his patents.
Conclusion
William Drell's contributions to the field of opioid treatment through his innovative patents highlight his dedication to improving patient care. His work continues to pave the way for advancements in medical treatments for opioid-induced side effects.